ACCLAIM-Lp(a) is a clinical research study for people who have or are at risk for heart disease, stroke, or peripheral artery disease. Lipoprotein(a…
ROMA:WOMEN is a prospective un-blinded randomized multicenter clinical trial. Patients will be randomized to a single arterial graft (SAG) or…
Aficamten is a next-generation small molecule cardiac myosin inhibitor being developed as a chronic, oral treatment for participants with…
The Corvia Atrial Shunt is an investigational cardiac implant designed to reduce heart failure symptoms such as fatigue, breathlessness and…
This is a prospective, multi-center, unblinded, randomized, controlled, and non-inferiority study comparing the EVA2 LVAS to the most recent…
This study is enrolling eligible patients who present to the Ben Taub Emergency Department with lower leg swelling caused by heart failure.
The goal…
Background: The standard of care treatment for a problem like this is to draw blood and check for a biomarker called troponin I. If these blood…
This study is enrolling patients who present to the Ben Taub Emergency Department with signs or symptoms of a heart attack.
The goal of the study is…
Gore® cardioform septal occluder and antiplatelet medical management for reduction of recurrent stroke in patients with patent foramen ovale (pfo):…
A phase 3, prospective, multicenter, double-blind, double-dummy, randomized, active controlled, parallel-group, group-sequential, adaptive, event-…